EUVIMED · CrossrefZeitschrift
Journal of Ovarian Research
ISSN 1757-2215 · Springer Science and Business Media LLC
Neueste Artikel
KELIM and post-chemotherapy CA-125 for assessing chemosensitivity in high-grade serous carcinoma
Association of the glycolipid index GLM7 with polycystic ovary syndrome: an exploratory mediation analysis of serum total testosterone
Characterization of the single-cell adaptive immune landscape and its clinical implications in high-grade serous ovarian cancer
Associations of cyst size, bilaterality, and age with serum anti-Müllerian hormone levels in women with ovarian endometriomas: a retrospective cohort study of 321 patients
The dual role of IFI27 in ovarian cancer: cell-autonomous pro-apoptotic effects versus non-cell-autonomous tumor-promoting functions mediated by KGN cells
Ddah1 deficiency promotes ADMA accumulation to exacerbate polycystic ovary syndrome by enhancing androgen receptor expression
Considerations on external validation, potential data leakage, and model selection in a PET/CT-based radiomics model predicting residual disease in ovarian cancer
The evolutionary trade-off hypothesis: polyendocrine metabolic ovarian syndrome and late age at menopause
Metabolic–endocrine–reproductive remodelling after metabolic and bariatric surgery in women with obesity and PMOS/PCOS: an evidence-tiered framework for precision care
Follicular development dynamics, ovarian response, and reproductive outcomes among three recombinant FSH preparations: a single-center retrospective cohort study
Impact of post-thaw incubation time on viability and neovascularization of cryopreserved human ovarian tissue
Machine learning based model to predict the recurrence after fertility sparing surgery in patients with borderline ovarian tumor
Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy
GnRHa pretreatment is associated with improved follicular preservation and graft function compared with combined oral contraceptive pretreatment after ovarian tissue vitrification and autotransplantation in mice
Artificial intelligence in ultrasound imaging for polycystic ovary syndrome (PCOS): methodological advances, bias, and clinical translation
ATG9B identified as a direct functional target of liensinine in attenuating autophagic dysfunction and pathogenesis of KGN cell and polycystic ovary syndrome mice
Integrating global burden of disease and genetic analyses to identify potential lipid-immune targets in gynecological malignancies
Defining metabolic heterogeneity in polyendocrine metabolic ovarian syndrome based on the MTHFR C677T polymorphism: the potential pathway role of homocysteine
Fuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial
SCAN-seq2 reveals mitochondrial metabolic alterations and proteostasis-related transcriptional signatures during human oocyte aging
Advances in the application of fluorescent probes for ovarian cancer
Relative estradiol response during controlled ovarian stimulation and cycle-level blastocyst formation after IVF/ICSI: a retrospective cohort study
Exploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance
Mitochondrial subpopulations in oocytes and cumulus cells exhibit distinct age-associated changes and selective plasticity in response to NMN supplementation
RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis
Bulk and single-cell multiomics insights into theca cell and granulosa cell dysfunction in polyendocrine metabolic ovarian syndrome
Association of ovarian inflammation and hormonal dysregulation: a candidate mechanism underlying polycystic ovary syndrome
Targeting monocyte dysregulation in ovarian cancer: insights from single-cell genomics and Mendelian randomization
Microfluidic lipid nanoparticles co-delivering siMOB1A and paclitaxel for ovarian cancer therapy
Erzhi Tiangui formula ameliorates ovarian aging by enhancing antioxidant defense via Nrf2/HO-1 signaling
EUVIMED